{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:40:04Z","timestamp":1793173204993,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T00:00:00Z","timestamp":1722643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T00:00:00Z","timestamp":1722643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100001125","name":"GAVI Alliance","doi-asserted-by":"publisher","award":["PP61690717A2"],"award-info":[{"award-number":["PP61690717A2"]}],"id":[{"id":"10.13039\/100001125","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-50944-3","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T06:02:15Z","timestamp":1722664935000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Effect of pneumococcal conjugate vaccine six years post-introduction on pneumococcal carriage in Ulaanbaatar, Mongolia"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0927-1731","authenticated-orcid":false,"given":"Claire","family":"von Mollendorf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuya","family":"Mungun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munkhchuluun","family":"Ulziibayar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3738-2976","authenticated-orcid":false,"given":"Paige","family":"Skoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Boelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0599-8645","authenticated-orcid":false,"given":"Cattram","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purevsuren","family":"Batsaikhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bujinlkham","family":"Suuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dashtseren","family":"Luvsantseren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorj","family":"Narangerel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5002-6565","authenticated-orcid":false,"given":"Bilegtsaikhan","family":"Tsolmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sodbayar","family":"Demberelsuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda D.","family":"Ortika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3883-2163","authenticated-orcid":false,"given":"Casey L.","family":"Pell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3962-4256","authenticated-orcid":false,"given":"Ashleigh","family":"Wee-Hee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica L.","family":"Nation","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Hinds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5542-0780","authenticated-orcid":false,"given":"Eileen M.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Kim","family":"Mulholland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3164-8849","authenticated-orcid":false,"given":"Catherine","family":"Satzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,3]]},"reference":[{"key":"50944_CR1","doi-asserted-by":"publisher","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","volume":"6","author":"B Wahl","year":"2018","unstructured":"Wahl, B. et al. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15. Lancet Glob Health 6, e744\u2013e757 (2018).","journal-title":"Lancet Glob Health"},{"key":"50944_CR2","unstructured":"International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub 2023. Available from: www.view-hub.org. (Accessed 03 April 2023)."},{"key":"50944_CR3","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1586\/erv.12.53","volume":"11","author":"B Simell","year":"2012","unstructured":"Simell, B. et al. The fundamental link between pneumococcal carriage and disease. Exp. Rev. Vaccines 11, 841\u2013855 (2012).","journal-title":"Exp. Rev. Vaccines"},{"key":"50944_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.vaccine.2013.05.005","volume":"32","author":"SM Davis","year":"2013","unstructured":"Davis, S. M., Deloria-Knoll, M., Kassa, H. T. & O\u2019Brien, K. L. Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects. Vaccine 32, 133\u2013145 (2013).","journal-title":"Vaccine"},{"key":"50944_CR5","doi-asserted-by":"publisher","first-page":"e365","DOI":"10.1016\/S2214-109X(14)70241-4","volume":"2","author":"KP Klugman","year":"2014","unstructured":"Klugman, K. P. Herd protection induced by pneumococcal conjugate vaccine. Lancet Glob Health 2, e365\u2013e366 (2014).","journal-title":"Lancet Glob Health"},{"key":"50944_CR6","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","volume":"378","author":"DM Weinberger","year":"2011","unstructured":"Weinberger, D. M., Malley, R. & Lipsitch, M. Serotype replacement in disease after pneumococcal vaccination. Lancet 378, 1962\u20131973 (2011).","journal-title":"Lancet"},{"key":"50944_CR7","doi-asserted-by":"publisher","first-page":"e1009389","DOI":"10.1371\/journal.pcbi.1009389","volume":"18","author":"A L\u00f8chen","year":"2022","unstructured":"L\u00f8chen, A., Truscott, J. E. & Croucher, N. J. Analysing pneumococcal invasiveness using Bayesian models of pathogen progression rates. PLoS Comput. Biol. 18, e1009389 (2022).","journal-title":"PLoS Comput. Biol."},{"key":"50944_CR8","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/S1473-3099(23)00706-5","volume":"24","author":"M Bertran","year":"2024","unstructured":"Bertran, M. et al. Invasive pneumococcal disease 3 years after introduction of a reduced 1\u2009+\u20091 infant 13-valent pneumococcal conjugate vaccine immunisation schedule in England: a prospective national observational surveillance study. Lancet Infect. Dis. 24, 546\u2013556 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"50944_CR9","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/S0140-6736(12)60588-1","volume":"379","author":"K Mulholland","year":"2012","unstructured":"Mulholland, K. & Satzke, C. Serotype replacement after pneumococcal vaccination. Lancet 379, 1387 (2012).","journal-title":"Lancet"},{"key":"50944_CR10","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1093\/aje\/kwt156","volume":"178","author":"DM Weinberger","year":"2013","unstructured":"Weinberger, D. M. et al. Using pneumococcal carriage data to monitor postvaccination changes in invasive disease. Am J Epidemiol 178, 1488\u20131495 (2013).","journal-title":"Am J Epidemiol"},{"key":"50944_CR11","doi-asserted-by":"publisher","first-page":"6299","DOI":"10.1016\/j.vaccine.2019.08.073","volume":"37","author":"J Chan","year":"2019","unstructured":"Chan, J. et al. Using pneumococcal carriage studies to monitor vaccine impact in low- and middle-income countries. Vaccine 37, 6299\u20136309 (2019).","journal-title":"Vaccine"},{"key":"50944_CR12","doi-asserted-by":"publisher","first-page":"e1494","DOI":"10.1016\/S2214-109X(22)00281-9","volume":"10","author":"S Shrestha","year":"2022","unstructured":"Shrestha, S. et al. Effect of the of 10-valent pneumococcal conjugate vaccine in Nepal 4 years after introduction: an observational cohort study. Lancet Glob. Health 10, e1494\u2013e1504 (2022).","journal-title":"Lancet Glob. Health"},{"key":"50944_CR13","doi-asserted-by":"publisher","first-page":"e1375","DOI":"10.1016\/S2214-109X(18)30383-8","volume":"6","author":"EM Dunne","year":"2018","unstructured":"Dunne, E. M. et al. Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumococcal carriage in Fiji: results from four annual cross-sectional carriage surveys. Lancet Glob. Health 6, e1375\u2013e1385 (2018).","journal-title":"Lancet Glob. Health"},{"key":"50944_CR14","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.vaccine.2018.10.077","volume":"37","author":"C Satzke","year":"2019","unstructured":"Satzke, C. et al. Pneumococcal carriage in vaccine-eligible children and unvaccinated infants in Lao PDR two years following the introduction of the 13-valent pneumococcal conjugate vaccine. Vaccine 37, 296\u2013305 (2019).","journal-title":"Vaccine"},{"key":"50944_CR15","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1093\/cid\/ciz481","volume":"70","author":"P Turner","year":"2020","unstructured":"Turner, P. et al. Impact of 13-valent Pneumococcal conjugate vaccine on colonization and invasive disease in Cambodian children. Clin. Infect Dis. 70, 1580\u20131588 (2020).","journal-title":"Clin. Infect Dis."},{"key":"50944_CR16","doi-asserted-by":"publisher","first-page":"5401","DOI":"10.1016\/j.vaccine.2021.07.085","volume":"39","author":"KJ Britton","year":"2021","unstructured":"Britton, K. J. et al. Lack of effectiveness of 13-valent pneumococcal conjugate vaccination against pneumococcal carriage density in Papua New Guinean infants. Vaccine 39, 5401\u20135409 (2021).","journal-title":"Vaccine"},{"key":"50944_CR17","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.1016\/j.vaccine.2019.05.078","volume":"37","author":"C von Mollendorf","year":"2019","unstructured":"von Mollendorf, C. et al. Pneumococcal carriage in children in Ulaanbaatar, Mongolia before and one year after the introduction of the 13-valent pneumococcal conjugate vaccine. Vaccine 37, 4068\u20134075 (2019).","journal-title":"Vaccine"},{"key":"50944_CR18","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1016\/j.vaccine.2023.03.063","volume":"41","author":"I Jagne","year":"2023","unstructured":"Jagne, I. et al. A systematic review of pneumococcal conjugate vaccine impact on pneumococcal nasopharyngeal colonisation density in children under 5 years of age. Vaccine 41, 3028\u20133037 (2023).","journal-title":"Vaccine"},{"key":"50944_CR19","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.1016\/S2666-5247(21)00064-1","volume":"2","author":"K Andrejko","year":"2021","unstructured":"Andrejko, K., Ratnasiri, B., Hausdorff, W. P., Laxminarayan, R. & Lewnard, J. A. Antimicrobial resistance in paediatric Streptococcus pneumoniae isolates amid global implementation of pneumococcal conjugate vaccines: a systematic review and meta-regression analysis. Lancet Microbe 2, e450\u2013e460 (2021).","journal-title":"Lancet Microbe"},{"key":"50944_CR20","unstructured":"CLSI. M100-ED29:2019 Performance Standards for Antimicrobial Susceptibility Testing 2019. Available from: https:\/\/clsi.org\/standards\/."},{"key":"50944_CR21","unstructured":"World Health Organization, UNICEF. Immunization 2024 Mongolia country profile. Available from: https:\/\/www.who.int\/publications\/m\/item\/immunization-2024-mongolia-country-profile (Accessed 20 July 2024)."},{"key":"50944_CR22","doi-asserted-by":"publisher","unstructured":"von Mollendorf C., et al. Changes in Pneumococcal Carriage in Hospitalised Children 2-59 Months of Age in Mongolia Following Pneumococcal Conjugate Vaccine Introduction. Available from: https:\/\/doi.org\/10.2139\/ssrn.4488943","DOI":"10.2139\/ssrn.4488943"},{"key":"50944_CR23","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ebiom.2019.04.021","volume":"43","author":"RA Gladstone","year":"2019","unstructured":"Gladstone, R. A. et al. International genomic definition of pneumococcal lineages, to contextualise disease, antibiotic resistance and vaccine impact. EBioMedicine 43, 338\u2013346 (2019).","journal-title":"EBioMedicine"},{"key":"50944_CR24","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.1016\/j.vaccine.2014.03.017","volume":"32","author":"AJ van Hoek","year":"2014","unstructured":"van Hoek, A. J. et al. Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England. Vaccine 32, 4349\u20134355 (2014).","journal-title":"Vaccine"},{"key":"50944_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15786-9","volume":"11","author":"TD Swarthout","year":"2020","unstructured":"Swarthout, T. D. et al. High residual carriage of vaccine-serotype Streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine in Malawi. Nat Commun 11, 2222 (2020).","journal-title":"Nat Commun"},{"key":"50944_CR26","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1093\/cid\/ciy726","volume":"68","author":"E Usuf","year":"2019","unstructured":"Usuf, E. et al. Persistence of nasopharyngeal pneumococcal vaccine serotypes and increase of nonvaccine serotypes among vaccinated infants and their mothers 5 Years after introduction of pneumococcal conjugate vaccine 13 in The Gambia. Clin Infect Dis 68, 1512\u20131521 (2019).","journal-title":"Clin Infect Dis"},{"key":"50944_CR27","doi-asserted-by":"publisher","first-page":"e397","DOI":"10.1016\/S2214-109X(14)70224-4","volume":"2","author":"LL Hammitt","year":"2014","unstructured":"Hammitt, L. L. et al. Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies. Lancet Glob Health 2, e397\u2013e405 (2014).","journal-title":"Lancet Glob Health"},{"key":"50944_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.vaccine.2010.10.032","volume":"29","author":"I Yildirim","year":"2010","unstructured":"Yildirim, I. et al. Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease. Vaccine 29, 283\u2013288 (2010).","journal-title":"Vaccine"},{"key":"50944_CR29","doi-asserted-by":"publisher","first-page":"S352","DOI":"10.1093\/infdis\/jiaa535","volume":"224","author":"GL Rodgers","year":"2021","unstructured":"Rodgers, G. L., Whitney, C. G. & Klugman, K. P. Triumph of Pneumococcal Conjugate Vaccines: Overcoming a Common Foe. The Journal of Infectious Diseases 224, S352\u2013S359 (2021).","journal-title":"The Journal of Infectious Diseases"},{"key":"50944_CR30","doi-asserted-by":"crossref","unstructured":"Hawkins P. A., et al. A global genomic perspective on the multidrug-resistant Streptococcus pneumoniae 15A-CC63 sub-lineage following pneumococcal conjugate vaccine introduction. Microb Genom. 9.2023","DOI":"10.1099\/mgen.0.000998"},{"key":"50944_CR31","doi-asserted-by":"publisher","first-page":"e1001903","DOI":"10.1371\/journal.pmed.1001903","volume":"12","author":"C Satzke","year":"2015","unstructured":"Satzke, C., Dunne, E. M., Porter, B. D., Klugman, K. P. & Mulholland, E. K. PneuCarriage project group. The PneuCarriage project: a multi-centre comparative study to identify the best serotyping methods for examining pneumococcal carriage in vaccine evaluation studies. PLoS Med. 12, e1001903 (2015).","journal-title":"PLoS Med."},{"key":"50944_CR32","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1016\/j.vaccine.2016.06.017","volume":"34","author":"C Valente","year":"2016","unstructured":"Valente, C. et al. Impact of the 13-valent pneumococcal conjugate vaccine on Streptococcus pneumoniae multiple serotype carriage. Vaccine 34, 4072\u20134078 (2016).","journal-title":"Vaccine"},{"key":"50944_CR33","doi-asserted-by":"publisher","first-page":"e30235","DOI":"10.1371\/journal.pone.0030235","volume":"7","author":"C Valente","year":"2012","unstructured":"Valente, C. et al. Decrease in pneumococcal co-colonization following vaccination with the seven-valent pneumococcal conjugate vaccine. PLoS ONE 7, e30235 (2012).","journal-title":"PLoS ONE"},{"key":"50944_CR34","doi-asserted-by":"crossref","unstructured":"Kandasamy, R. et al. Decline in pneumococcal vaccine serotype carriage, multiple-serotype carriage, and carriage density in Nepalese children after PCV10 introduction: A pre-post comparison study. Vaccine, (2024).","DOI":"10.1016\/j.vaccine.2024.05.018"},{"key":"50944_CR35","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1093\/cid\/cis554","volume":"55","author":"A Roca","year":"2012","unstructured":"Roca, A. et al. Effect of age and vaccination with a pneumococcal conjugate vaccine on the density of pneumococcal nasopharyngeal carriage. Clin Infect. Dis. 55, 816\u2013824 (2012).","journal-title":"Clin Infect. Dis."},{"key":"50944_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-13-379","volume":"13","author":"G Dorj","year":"2013","unstructured":"Dorj, G., Hendrie, D., Parsons, R. & Sunderland, B. An evaluation of prescribing practices for community-acquired pneumonia (CAP) in Mongolia. BMC Health Serv. Res. 13, 379 (2013).","journal-title":"BMC Health Serv. Res."},{"key":"50944_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9160296","volume":"2019","author":"G Dorj","year":"2019","unstructured":"Dorj, G. et al. Antibiotic Utilization Trends in Two State Hospitals of Mongolia from 2013 to 2017. BioMed Res. Int. 2019, 9160296 (2019).","journal-title":"BioMed Res. Int."},{"key":"50944_CR38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ijid.2020.09.275","volume":"101","author":"G Dorj","year":"2020","unstructured":"Dorj, G. et al. National surveillance of antibiotic consumption in Mongolia. Int. J. Infect. Dis. 101, 96 (2020).","journal-title":"Int. J. Infect. Dis."},{"key":"50944_CR39","unstructured":"Center for Health Development. Health Statistics Information Database: Ministry of Health, Mongolia; 2023. Available from: https:\/\/1313.mn\/ (Accessed 06 Jan 2023)."},{"key":"50944_CR40","doi-asserted-by":"publisher","first-page":"e1154","DOI":"10.1093\/cid\/ciab1014","volume":"75","author":"D Danino","year":"2022","unstructured":"Danino, D. et al. Decline in Pneumococcal disease in Young children during the coronavirus disease 2019 (COVID-19) pandemic in Israel associated With Suppression of Seasonal Respiratory Viruses, Despite Persistent Pneumococcal Carriage: A Prospective Cohort Study. Clin Infect Dis 75, e1154\u2013e1164 (2022).","journal-title":"Clin Infect Dis"},{"key":"50944_CR41","doi-asserted-by":"publisher","first-page":"e2218959","DOI":"10.1001\/jamanetworkopen.2022.18959","volume":"5","author":"A Rybak","year":"2022","unstructured":"Rybak, A. et al. Association of Nonpharmaceutical Interventions During the COVID-19 Pandemic With Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections Among Children in France. JAMA Netw Open 5, e2218959 (2022).","journal-title":"JAMA Netw Open"},{"key":"50944_CR42","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.vaccine.2013.08.062","volume":"32","author":"C Satzke","year":"2013","unstructured":"Satzke, C. et al. Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization Pneumococcal Carriage Working Group. Vaccine 32, 165\u2013179 (2013).","journal-title":"Vaccine"},{"key":"50944_CR43","doi-asserted-by":"crossref","unstructured":"Belman S., et al. Genetic background of Cambodian pneumococcal carriage isolates following pneumococcal conjugate vaccine 13. Microbial Genomics, 8. 2022","DOI":"10.1099\/mgen.0.000837"},{"key":"50944_CR44","doi-asserted-by":"crossref","unstructured":"Javaid N., et al. Strain features of pneumococcal isolates in the pre- and post-PCV10 era in Pakistan. Microbial Genomics. 2024;10.","DOI":"10.1099\/mgen.0.001163"},{"key":"50944_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-019-6639-y","volume":"19","author":"SF La Vincente","year":"2019","unstructured":"La Vincente, S. F. et al. Evaluation of a phased pneumococcal conjugate vaccine introduction in Mongolia using enhanced pneumonia surveillance and community carriage surveys: a study protocol for a prospective observational study and lessons learned. BMC Public Health 19, 333 (2019).","journal-title":"BMC Public Health"},{"key":"50944_CR46","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1099\/mic.0.056580-0","volume":"158","author":"SJ Salter","year":"2012","unstructured":"Salter, S. J. et al. Variation at the capsule locus, cps, of mistyped and non-typable Streptococcus pneumoniae isolates. Microbiology 158, 1560\u20131569 (2012).","journal-title":"Microbiology"},{"key":"50944_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris, P. A. et al. The REDCap consortium: building an international community of software platform partners. J. Biomed. Inf. 95, 103208 (2019).","journal-title":"J. Biomed. Inf."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50944-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50944-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50944-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T06:02:46Z","timestamp":1722664966000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50944-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,3]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["50944"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-50944-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,3]]},"assertion":[{"value":"25 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.V.M., M.U., C.D.N., P.B., B.S., D.L., C.S., T.M., and E.K.M. are investigators on a Pfizer collaborative research project, exploring the impact of PCV13 introduction on adult pneumonia in Mongolia, outside this work. E.M.D. is currently employed by Pfizer. C.S., E.K.M., and C.D.N. are investigators on a Merck Investigator Studies Program grant funded by MSD outside this work. C.V.M. has participated in expert forums for Pfizer and MSD. C.S. has participated in forums and seminars for Pfizer and MSD. J.H. is co-founder and shareholder of BUGS Bioscience Ltd., a not-for-profit spin-out company of St George\u2019s, University of London. The remaining authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6577"}}